Cargando…
Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
BACKGROUND: Acinetobacter calcoaceticus–A. baumannii (Acb) complex and Stenotrophomonas maltophilia represent frequent causes of hospital-acquired infections. We evaluated the frequency and resistance rates of Acb complex and S. maltophilia isolates from medical centers enrolled in the SENTRY Progra...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419908/ https://www.ncbi.nlm.nih.gov/pubmed/30895213 http://dx.doi.org/10.1093/ofid/ofy293 |
_version_ | 1783404023406133248 |
---|---|
author | Gales, Ana C Seifert, Harald Gur, Deniz Castanheira, Mariana Jones, Ronald N Sader, Helio S |
author_facet | Gales, Ana C Seifert, Harald Gur, Deniz Castanheira, Mariana Jones, Ronald N Sader, Helio S |
author_sort | Gales, Ana C |
collection | PubMed |
description | BACKGROUND: Acinetobacter calcoaceticus–A. baumannii (Acb) complex and Stenotrophomonas maltophilia represent frequent causes of hospital-acquired infections. We evaluated the frequency and resistance rates of Acb complex and S. maltophilia isolates from medical centers enrolled in the SENTRY Program. METHODS: A total of 13 752 Acb complex and 6467 S. maltophilia isolates were forwarded to a monitoring laboratory by 259 participating sites from the Asia-Pacific region, Latin America, Europe, and North America between 1997 and 2016. Confirmation of species identification and antimicrobial susceptibility testing were performed using conventional methods and/or matrix-assisted laser desorption ionization–time of flight mass spectrometry and the broth microdilution method, respectively. Antimicrobial susceptibility results were interpreted by CLSI and EUCAST 2018 criteria. RESULTS: Acb complex and S. maltophilia were most frequently isolated from patients hospitalized with pneumonia (42.9% and 55.8%, respectively) and bloodstream infections (37.3% and 33.8%, respectively). Colistin and minocycline were the most active agents against Acb complex (colistin MIC(50/90), ≤0.5/2 mg/L; 95.9% susceptible) and S. maltophilia (minocycline MIC(50/90), ≤1/2 mg/L; 99.5% susceptible) isolates, respectively. Important temporal decreases in susceptibility rates among Acb complex isolates were observed for all antimicrobial agents in all regions. Rates of extensively drug-resistant Acb complex rates were highest in Europe (66.4%), followed by Latin America (61.5%), Asia-Pacific (56.9%), and North America (38.8%). Among S. maltophilia isolates, overall trimethoprim-sulfamethoxazole (TMP-SMX) susceptibility rates decreased from 97.2% in 2001–2004 to 95.7% in 2013–2016, but varied according to the geographic region. CONCLUSIONS: We observed important reductions of susceptibility rates to all antimicrobial agents among Acb complex isolates obtained from all geographic regions. In contrast, resistance rates to TMP-SMX among S. maltophilia isolates remained low and relatively stable during the study period. |
format | Online Article Text |
id | pubmed-6419908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-64199082019-03-20 Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) Gales, Ana C Seifert, Harald Gur, Deniz Castanheira, Mariana Jones, Ronald N Sader, Helio S Open Forum Infect Dis Supplement Article BACKGROUND: Acinetobacter calcoaceticus–A. baumannii (Acb) complex and Stenotrophomonas maltophilia represent frequent causes of hospital-acquired infections. We evaluated the frequency and resistance rates of Acb complex and S. maltophilia isolates from medical centers enrolled in the SENTRY Program. METHODS: A total of 13 752 Acb complex and 6467 S. maltophilia isolates were forwarded to a monitoring laboratory by 259 participating sites from the Asia-Pacific region, Latin America, Europe, and North America between 1997 and 2016. Confirmation of species identification and antimicrobial susceptibility testing were performed using conventional methods and/or matrix-assisted laser desorption ionization–time of flight mass spectrometry and the broth microdilution method, respectively. Antimicrobial susceptibility results were interpreted by CLSI and EUCAST 2018 criteria. RESULTS: Acb complex and S. maltophilia were most frequently isolated from patients hospitalized with pneumonia (42.9% and 55.8%, respectively) and bloodstream infections (37.3% and 33.8%, respectively). Colistin and minocycline were the most active agents against Acb complex (colistin MIC(50/90), ≤0.5/2 mg/L; 95.9% susceptible) and S. maltophilia (minocycline MIC(50/90), ≤1/2 mg/L; 99.5% susceptible) isolates, respectively. Important temporal decreases in susceptibility rates among Acb complex isolates were observed for all antimicrobial agents in all regions. Rates of extensively drug-resistant Acb complex rates were highest in Europe (66.4%), followed by Latin America (61.5%), Asia-Pacific (56.9%), and North America (38.8%). Among S. maltophilia isolates, overall trimethoprim-sulfamethoxazole (TMP-SMX) susceptibility rates decreased from 97.2% in 2001–2004 to 95.7% in 2013–2016, but varied according to the geographic region. CONCLUSIONS: We observed important reductions of susceptibility rates to all antimicrobial agents among Acb complex isolates obtained from all geographic regions. In contrast, resistance rates to TMP-SMX among S. maltophilia isolates remained low and relatively stable during the study period. Oxford University Press 2019-03-15 /pmc/articles/PMC6419908/ /pubmed/30895213 http://dx.doi.org/10.1093/ofid/ofy293 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Supplement Article Gales, Ana C Seifert, Harald Gur, Deniz Castanheira, Mariana Jones, Ronald N Sader, Helio S Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) |
title | Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) |
title_full | Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) |
title_fullStr | Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) |
title_full_unstemmed | Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) |
title_short | Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) |
title_sort | antimicrobial susceptibility of acinetobacter calcoaceticus–acinetobacter baumannii complex and stenotrophomonas maltophilia clinical isolates: results from the sentry antimicrobial surveillance program (1997–2016) |
topic | Supplement Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419908/ https://www.ncbi.nlm.nih.gov/pubmed/30895213 http://dx.doi.org/10.1093/ofid/ofy293 |
work_keys_str_mv | AT galesanac antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016 AT seifertharald antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016 AT gurdeniz antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016 AT castanheiramariana antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016 AT jonesronaldn antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016 AT saderhelios antimicrobialsusceptibilityofacinetobactercalcoaceticusacinetobacterbaumanniicomplexandstenotrophomonasmaltophiliaclinicalisolatesresultsfromthesentryantimicrobialsurveillanceprogram19972016 |